Rm-493-022
Research payments
$1,972,701
Through program year 2023, $1,972,701 in research payments was reported against Rm-493-022, across 191 payments, paid by Rhythm Pharmaceuticals, Inc..
- Paid by
- Rhythm Pharmaceuticals, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | Research | $751,674 | 74 |
| 2022 | Research | $695,291 | 70 |
| 2021 | Research | $525,736 | 47 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
8 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- James Swain Scottsdale, AZ Named on 22 payments
- Christopher Still Danville, PA Named on 20 payments
- Ahlee Kim Memphis, TN Named on 15 payments
- Erin Cooksey Anderson, SC Named on 11 payments
- Indrajit Majumdar Buffalo, NY Named on 11 payments
- Matthew Hong North Cape May, NJ Named on 11 payments
- Shana McCormack Philadelphia, PA Named on 10 payments
- Elif Oral Ann Arbor, MI Named on 7 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.